Article thumbnail

Hypothermia as an Adjunct Therapy to Vesicant-induced Skin Injury

By Thomas W Sawyer and Peggy Nelson

Abstract

Objective: The notion that cooling vesicant-exposed tissue may ameliorate or prevent resultant injury is not a novel concept. During both World Wars, studies were conducted that investigated this potential mode of therapy with sulfur mustard and seemed to conclude that there might be merit in pursuing this research direction. However, it does not appear that these studies were followed up vigorously, and the literature that describes this work is not readily accessible. In this report, we compare the toxicities of lewisite and sulfur mustard in vitro and in vivo and also provide an overview of historical and recent work on the effect of temperature on the toxicity of these vesicating chemical warfare agents.Methods: Tissue culture and animal studies were utilized to examine the effects of hypothermia on vesicant-induced toxicity. Results: Cytotoxicity was either significantly delayed (lewisite) or prevented (sulfur mustard) when cultures were maintained at 25°C. However, the effects of hypothermia on sulfur mustard–induced cell death were reversible when the cells were returned to 37°C. Despite these in vitro results, animal studies demonstrated that the therapeutic cooling of both mustard sulfur–exposed and lewisite-exposed skin resulted in dramatic and permanent protection against injury. Cooling also increased the therapeutic window in which drugs were effective against vesicant agents in tissue culture and lewisite-induced skin injury. Conclusions: The simple and noninvasive application of cooling measures may not only provide significant therapeutic relief to vesicant-exposed skin but also increase the therapeutic window in which medical countermeasures against vesicant agents are useful

Topics: Article
Publisher: Open Science Company, LLC
OAI identifier: oai:pubmedcentral.nih.gov:2374499
Provided by: PubMed Central

Suggested articles

Citations

  1. (1984). A Biography.T oronto,
  2. (1984). and DMPA—as arsenic antidotes. Fundam Appl Toxicol.
  3. (1982). Anti-lewisite activity and stability of meso-dimercaptosuccinic acid and 2,3-dimercapto-1-propanesulfonic acid. Life Sci.
  4. (1998). AverillDA,LarriveeB.Hyperthermia,cyclosporineAandmelphalancytotoxicityandtransportinmultidrug resistant cells.
  5. (1982). Biological chelation: 2, 3-dimercaptopropanesulfonic acid and meso-dimercaptosuccinic acid. Adv Enzyme Regul.
  6. (1969). Body temperature and responses to drugs. Br Med Bull.
  7. Characterization of the protective effects of L-nitroarginine methyl ester (L-NAME) against the toxicity of sulphur mustard in vitro.
  8. (1949). Chemical mutagenesis. Biol Rev.
  9. Chemical production of mutation.
  10. (1996). Chlorpromazine-induced hypothermia: effect of tumour progression and survival in mice. Anticancer Res.
  11. (1989). Clinical management of mustard gas casualties. Annales Medicinae Militaris Belgicae.
  12. (1947). Development and theoretical significance of British anti-lewisite (BAL). Br Med Bull.
  13. (1971). Disaster at Bari.
  14. Effect of low temperature on the toxicity of sulphur mustard in vitro and in vivo.
  15. (1993). Efficacy of dimercapto chelating agents for the treatment of poisoning by percutaneously applied dichloro (2-chlorovinyl) arsine in rabbits. Human Exp Toxicol.
  16. (1990). Evaluation of the efficacy of dimercapto chelating agents for the treatment of systemic organic arsenic poisoning in rabbits. Human Exp Toxicol.
  17. (2003). Hypothermia reduces sulphur mustard toxicity. Toxicol Appl Pharmacol.
  18. (1989). Lewisite: its chemistry, toxicology and biological effects. Rev Environ Contam Toxicol.
  19. Ling CC. Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro.
  20. (1946). Mechanisms in production of cutaneous injuries by sulfur and nitrogen mustards. In: Chemical Warfare Agents, and Related Chemical Problems—Parts III–VI. Summary technical report of Division 9.
  21. Medical Aspects of Gas Warfare.
  22. Medical aspects of sulphur mustard poisoning.
  23. (1991). Medical defence against blistering chemical warfare agents. Arch Dermatol.
  24. (1947). Medical report of the Bari Harbor casualties. Milit Surg.
  25. (1990). MershonMM,MitcheltreeLW,PetraliJP,BrauEH,WadeJV .Hairlessguineapigmodelbioassayforvesicant vapor exposures. Fundam Appl Toxicol.
  26. (1998). Modulation of sulfur mustard toxicity by arginine analogues and related nitric oxide synthase inhibitors in vitro. Toxicol Sci.
  27. Notes on the Meeting of the Physiological Mechanisms Committee (B4-C) held in
  28. (1946). Office of Scientific Research and Development. Chemical Warfare Agents, and Related Chemical Problems—Parts III–IV . Summary technical report of Division 9.
  29. On dichloroethylsulphide (mustard gas). Part I: the systemic effects and mechanism of action.
  30. (1996). Protective effect of an inhibitor of nitric oxide synthase on sulphur mustard toxicity in vitro. Toxicol Appl Pharmacol.
  31. (2001). Radio and chemotherapy in mice during hypothermia. Anticancer Res.
  32. The clinical and pathologic effects of the nitrogen and sulfur mustards in laboratory animals.
  33. The clinical features of mustard-gas poisoning
  34. (1973). The effect of temperature on the action of drugs. Ann Rev Pharmacol.
  35. The effect of various chemotherapeutic agents given with mild hyperthermia on different types of tumours.
  36. The Medical Aspects of Mustard Gas Poisoning.S tLouis,
  37. (2006). The Skin Reservoir of Sulphur Mustard:
  38. (2002). Therapeutic effects of cooling swine skin exposed to sulfur mustard. Milit Med.
  39. Therapeutic effects of hypothermia on Lewisite toxicity.
  40. (1999). Toxicity of sulphur mustard in primary neuron culture. Toxicol Vitr

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.